Intersect ENT (XENT) Tops Q3 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
• Primis Financial (FRST) Misses Q1 EPS by 8c